Beiken Technology Secures Strategic Investment from CEC Health Industry Fund to Advance Medical Data Integration and Primary Healthcare Solutions

VCBeat (WeChat ID: vcbeat) has learned that Biochem Technology, a leading provider of comprehensive solutions in China’s healthcare sector, has received strategic investment from the CEC Health Industry Fund. The two parties have established a strategic partnership and will collaborate on areas such as medical data integration and enhancing primary healthcare capabilities.

As a leading provider of comprehensive solutions in China’s healthcare and medical sector, Biochem Technology has accumulated extensive client resources and data over the years across multiple fields, including primary healthcare, military medical services, and food safety.

On one hand, Biochem Technology focuses on grassroots healthcare by vigorously promoting a series of comprehensive solutions, including “Two-Cancer” screening and women’s disease prevention and treatment centers, chest pain centers, and digital laboratories for township health centers. This strategy facilitates the decentralization of high-quality medical resources, supports the upgrading of primary healthcare institutions, rapidly enhances diagnostic and therapeutic capabilities as well as service quality, and serves a broader base of healthcare providers and patients.

On the other hand, Biochem Technology boasts robust capabilities in designing comprehensive solutions and continuously pursues technological and business model innovation. From one-stop cloud-network-device solutions to AI-assisted screening, and from coagulation reagent R&D to the design of specialized POCT diagnostic products, Biochem Technology excels at deeply integrating technology, business models, and application scenarios.

Beiken Technology positions itself strategically as an innovation hub for solutions in the health services sector. Through technological, platform, and business and service model innovations, it integrates complex, high-cost technologies into simple, user-friendly, cost-effective, and highly tailored cloud-network-device one-stop solutions that closely meet user needs. Its solutions—including digital integrated laboratories, workstations for village doctors and general practitioners, intelligent food safety supervision, field (emergency) rapid testing, pre-hospital emergency systems for cardiovascular events (a key supporting technology for Chest Pain Center development), internet-based chronic disease monitoring and diagnosis/treatment, and coagulation testing—have been successfully deployed across China’s food and drug administration systems, tertiary hospitals, and primary healthcare institutions. These solutions provide robust technical support for primary healthcare, precision medicine, intelligent food safety regulation, modern military medical logistics, emergency rescue, and Chest Pain Center capacity building in China.

Li Shifeng, Chairman of CEC Data and Managing Partner of the CEC Health Industry Fund, stated, “CEC Data is the national team for the development of the health and medical big data industry, established under the guidance of the National Health Commission and led by China Electronics Corporation (CEC). CEC Data exerts efforts from multiple perspectives, including technology, platform construction, and industrial investment. As a crucial capital link in CEC Data’s ecosystem layout, the CEC Health Industry Fund focuses on investing in highly relevant fields radiating from the health and medical data industry, such as Fintech, Biotech, artificial intelligence, and next-generation internet technologies. With the continuous implementation of medical informatization, how to utilize massive amounts of medical big data more compliantly, securely, and effectively to better support healthcare services has become an important direction and key topic in current medical informatization and ‘Internet+ Healthcare.’ We are optimistic about Biochem Technology’s technical strength and business model. As a significant strategic investment of the CEC Health Industry Fund in primary healthcare and AI applications, Biochem Technology will collaborate with us in areas such as medical data integration and enhancing primary healthcare capabilities. Together, we will promote supply chain integration and business implementation, leverage our respective advantages, jointly create a new landscape for China’s health and medical big data, strengthen the leading and supporting role of technology in building a ‘Healthy China,’ and tangibly improve the people’s sense of gain.”